Synthesis and characterization of two new mixed‐ligand Cu (II) complexes of a tridentate NN'O type Schiff base ligand and N‐donor heterocyclic co‐ligands: In vitro anticancer … L Ghasemi, M Behzad, A Khaleghian, A Abbasi, A Abedi Applied Organometallic Chemistry 36 (5), e6639, 2022 | 22 | 2022 |
Synthesis and crystal structures of new mixed-ligand schiff base complexes containing N-donor heterocyclic co-ligands: Molecular docking and pharmacophore modeling studies on … L Ghasemi, MH Esfahani, A Abbasi, M Behzad Polyhedron 220, 115825, 2022 | 17 | 2022 |
Design, spectroscopic, and crystal structural characterization of new pyrazolone-based schiff bases: molecular docking investigations against SARS-Covid-19 main proteases (PDB … M Hasanzadeh Esfahani, L Ghasemi, M Behzad, E Skorepova, M Dusek Polycyclic Aromatic Compounds 43 (10), 8933-8945, 2023 | 7 | 2023 |
A pyrazolone-based dinuclear Cu (II) Schiff-base complex: DFT studies on the rate-determining steps of the tautomerism in the ligand and molecular docking modelling with COVID … L Ghasemi, M Behzad, A Gharib, A Arab, A Abbasi Journal of Coordination Chemistry 76 (5-6), 830-846, 2023 | 2 | 2023 |
Experimental and molecular docking investigation of anticancer activity of new mixed-ligand Schiff base complexes against human colorectal (HCT116), lung (A549) and breast … L Ghasemi, MH Esfahani, U Sahebi, A Divsalar, A Abbasi, M Behzad Journal of Molecular Structure 1294, 136568, 2023 | 1 | 2023 |
Subtle structural variations in new mixed-ligand Cu (II) complexes with NN'O type unsymmetrical Schiff bases: Molecular docking against SARS-Cov-2 and its Omicron variant main … L Ghasemi, A Abedi, A Abbasi, M Kucerakova, M Dusek, M Behzad Inorganic Chemistry Communications 159, 111795, 2024 | | 2024 |
The effect of structural variations of heteroleptic Cu (II) complexes of tri‐dentate unsymmetrical Schiff‐base main ligands with pyridine or bithiazole co‐ligands on molecular … L Ghasemi, M Behzad, A Abedi, A Khaleghian Applied Organometallic Chemistry 37 (11), e7256, 2023 | | 2023 |